REVB
Revelation Biosciences, Inc.0.9825
+0.0225+2.34%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
5.82MP/E (TTM)
0.01Basic EPS (TTM)
81.25Dividend Yield
0%Recent Filings
8-K
10-Q
8-K
8-K
Special meeting canceled
Revelation Biosciences canceled its adjourned Special Meeting of Stockholders on October 29, 2025, due to technical issues preventing full shareholder voting, unrelated to the company. A new record date of October 29 sets the stage for a rescheduled meeting on December 3, with fresh proxy materials forthcoming. This delay disrupts timely decision-making on key proposals. Stockholders, vote promptly.
8-K
Special meeting adjourned
Revelation Biosciences adjourned its special stockholder meeting from October 15, 2025, to October 29, 2025, due to insufficient quorum. The delay allows more time for voting on undisclosed proposals outlined in proxy materials. Stockholders are urged to vote promptly. This postponement highlights challenges in securing participation amid the company's clinical-stage focus on inflammation therapies.
IPO
Employees
Sector
Industry
ENVB
Enveric Biosciences, Inc.
5.24-0.12
IMA
ImageneBio, Inc.
6.25+0.08
INBX
Inhibrx Biosciences, Inc.
81.57+5.36
KALA
KALA BIO, Inc.
0.56-0.05
NUVB
Nuvation Bio Inc.
8.66+0.15
RENB
Lunai Bioworks Inc.
1.42+0.00
RNXT
RenovoRx, Inc.
0.84-0.10
RVPH
Reviva Pharmaceuticals Holdings
0.64+0.01
RVRC
REVIUM RECOVERY INC
0.52+0.00
TRML
Tourmaline Bio, Inc.
47.98+47.98